Cargando…

Effect of duodenal-jejunal bypass surgery on glycemic control in type 2 diabetes: a randomized controlled trial

OBJECTIVE: To determine whether upper gastrointestinal tract (UGI) bypass itself has beneficial effects on the factors involved in regulating glucose homeostasis in patients with type 2 diabetes (T2D). METHODS: A 12-month randomized controlled trial was conducted in 17 overweight/obese subjects with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petry, Tarissa Z., Fabbrini, Elisa, Otoch, Jose P., Carmona, Murilo A., Caravatto, Pedro P., Salles, João E., Sarian, Thais, Correa, Jose L., Schiavon, Carlos A., Patterson, Bruce W., Cohen, Ricardo, Klein, Samuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603288/ https://www.ncbi.nlm.nih.gov/pubmed/26414562 http://dx.doi.org/10.1002/oby.21190

Ejemplares similares

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation
por: Betzel, B., et al.
Publicado: (2019)

Duodenal-jejunal bypass liner implantation provokes rapid weight loss and improved glycemic control, accompanied by elevated fasting ghrelin levels
por: Koehestanie, Parweez, et al.
Publicado: (2014)

The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
por: Ruban, Aruchuna, et al.
Publicado: (2018)

Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial
por: Cohen, Ricardo V., et al.
Publicado: (2022)

Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
por: Okikawa, Shohei, et al.
Publicado: (2023)

Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial
por: Cohen, Ricardo Vitor, et al.
Publicado: (2017)

Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial
por: Ruban, Aruchuna, et al.
Publicado: (2022)

Absence of Role of Dietary Protein Sensing in the Metabolic Benefits of Duodenal-Jejunal Bypass in the Mouse
por: Barataud, Aude, et al.
Publicado: (2017)

Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass
por: CHEN, XUAN, et al.
Publicado: (2014)

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
por: Ryder, Robert E.J., et al.
Publicado: (2023)

Duodenal-Jejunal Bypass Surgery Reverses Diabetic Phenotype and Reduces Obesity in db/db Mice
por: Liang, Yongjun, et al.
Publicado: (2017)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

DUODENAL-JEJUNAL BYPASS REDUCES LIPID ACCUMULATION IN THE BROWN ADIPOSE TISSUE OF HYPOTHALAMIC OBESE RATS
por: CEGLAREK, Vanessa Marieli, et al.
Publicado: (2020)

Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus
por: Chen, Ji-Hua, et al.
Publicado: (2022)

Conversion of Roux-en-Y gastric bypass to single anastomosis duodenal ileal bypass with sleeve gastrectomy with gastrogastric jejunal bridge
por: Dib, Victor Ramos Mussa, et al.
Publicado: (2022)

Duodenal-Jejunal Bypass Surgery Stimulates the Expressions of Hepatic Sirtuin1 and 3 and Hypothalamic Sirtuin1
por: Ha, Eunyoung, et al.
Publicado: (2018)

Duodenal and jejunal Dieulafoy’s lesions: optimal management
por: Yılmaz, Tonguç Utku, et al.
Publicado: (2017)

Effects and mechanism of duodenal-jejunal bypass and sleeve gastrectomy on GLUT2 and glucokinase in diabetic Goto–Kakizaki rats
por: Donglei, Zhou, et al.
Publicado: (2012)

miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal–jejunal bypass
por: Guo, W, et al.
Publicado: (2016)

Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats
por: Cantelli, K.R., et al.
Publicado: (2017)

A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease
por: Ghoz, Hassan, et al.
Publicado: (2020)

The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
por: Gao, Yi, et al.
Publicado: (2021)

Alteration of Ileal lncRNAs After Duodenal–Jejunal Bypass Is Associated With Regulation of Lipid and Amino Acid Metabolism
por: Liang, Yongjun, et al.
Publicado: (2022)

Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis
por: Karlas, Thomas, et al.
Publicado: (2022)

Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats
por: Han, Hai-Feng, et al.
Publicado: (2022)

Development of the duodenal, ileal, jejunal and caecal microbiota in chickens
por: Glendinning, Laura, et al.
Publicado: (2019)

Does Bypass of the Proximal Small Intestine Impact Food Intake, Preference, and Taste Function in Humans? An Experimental Medicine Study Using the Duodenal-Jejunal Bypass Liner
por: Aldhwayan, Madhawi M., et al.
Publicado: (2022)

Duodenal-jejunal bypass reduces serum ceramides via inhibiting intestinal bile acid-farnesoid X receptor pathway
por: Cheng, Zhi-Qiang, et al.
Publicado: (2022)

Feasibility of a new bariatric fully endoscopic duodenal-jejunal bypass: a pilot study in adult obese pigs
por: Gonzalez, Jean-Michel, et al.
Publicado: (2022)

The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study
por: van Rijn, Selwyn, et al.
Publicado: (2017)

A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
por: Glaysher, Michael Alan, et al.
Publicado: (2017)

Concurrent Placements of a Duodenal-Jejunal Bypass Liner and an Intragastric Balloon Among Severely Obese Patients: A Case Series
por: Sartoretto, Adrian, et al.
Publicado: (2019)

FIXING JEJUNAL MANEUVER TO PREVENT PETERSEN HERNIA IN GASTRIC BYPASS
por: MURAD-JUNIOR, Abdon José, et al.
Publicado: (2015)

Application of Jejunal Nutrient Tube in Congenital Duodenal Obstruction in Children
por: CAO, Junhua, et al.
Publicado: (2018)

ASSESSMENT OF THE GASTRO-JEJUNO-DUODENAL TRANSIT AFTER JEJUNAL POUCH INTERPOSITION
por: da SILVA, Alcino Lázaro, et al.
Publicado: (2015)

Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service
por: Ryder, Robert E. J., et al.
Publicado: (2022)

Single-Anastomosis Duodenal Jejunal Bypass Improve Glucose Metabolism by Regulating Gut Microbiota and Short-Chain Fatty Acids in Goto-Kakisaki Rats
por: Yu, Xiang, et al.
Publicado: (2020)

Glycemic Control during Coronary Artery Bypass Graft Surgery
por: Lazar, Harold L.
Publicado: (2012)

Pseudo Double Bubble: Jejunal Duplication Mimicking Duodenal Atresia on Prenatal Ultrasound
por: Schwartzberg, David, et al.
Publicado: (2013)

Duodenitis‐Proximal Jejunitis in Horses After Experimental Administration of Clostridium difficile Toxins
por: Arroyo, L.G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5hvd9buo2n70a7esn1amub23ra